Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03960463 · ClinicalTrials.gov registry record · NA
EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03960463 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 33 participants.
The verdict
NCT03960463, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The investigators will test the efficacy of the novel oxygen diffusion dressing allows delivery tissue oxygenation via TransCu O2® Oxygen Delivery System for use in caring for patients with surgically closed wounds. The investigators hypothesize that using this novel oxygen diffusion dressing will reduce the likelihood of necrotic tissue as well as severe incisional scar post-surgical closure by improving transcutaneous oxygen levels during wound healing process. TransCu O2 Oxygen Delivery System is a novel wound healing therapy that promises to enhance tissue hydration, which in turn may lead to quick epithelialization essential to reduce the likelihood of formation of necrotic tissue and excessive scars.
Interventions
- DEVICE Transcu O2®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-05-18 |
| Est. Completion | 2024-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03960463
The ClinicalTrials.gov registry entry for NCT03960463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcu O2® is the first listed.
NCT03960463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03960463 about?
NCT03960463 is a clinical study titled "EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds". The investigators will test the efficacy of the novel oxygen diffusion dressing allows delivery tissue oxygenation via TransCu O2® Oxygen Delivery System for use in caring for patients with surgically closed wounds. The investigators hypothesize that using this novel oxygen diffusion dressing will ...
What is the current status of trial NCT03960463?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-05-18. Estimated completion is 2024-07-24.
What interventions are being tested in trial NCT03960463?
The interventions under investigation include: Transcu O2® (DEVICE).
Who is sponsoring clinical trial NCT03960463?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.